Positive data on depression treatment based on a drug related to the psychedelic DMT is breathing life into shares of biotechs working on psychedelic medicines, after years of disappointments. Just as ...

A newly approved medication to treat postpartum depression will cost $15,900 per 14-day course, before insurance, when it reaches the market later this year, raising concerns among doctors and ...

When prescription depression drugs fall short in efficacy, there’s an off-label way to help them work better: add-on doses of thyroid hormone. Clinicians have long known about this approach and some ...

I'm Janet Babin. Today on the podcast, how the hallucinogenic compound psilocybin, once associated with 1960s drug culture, is making a comeback and giving people suffering from depression and other ...

This story discusses suicide. If you or someone you know is having thoughts of suicide, please contact the Suicide & Crisis Lifeline at 988 or 1-800-273-TALK (8255). Millions of men undergoing hair ...

Dr. David Brendel answers the question: 'Substance Abuse And Depression?' — -- Question: What is the relationship between depression and substance abuse? Answer: There is a very close ...

An experimental depression drug that joined the Neurocrine Biosciences pipeline as part of a broader package from Takeda Pharmaceutical failed to meet the main goal of a mid-stage clinical trial. The ...

Share on Pinterest In a recent interview, Elon Musk revealed he takes ketamine to help boost his mental health and treat symptoms of depression. STR/NurPhoto via Getty Images In a recent interview, ...

For the millions of people who take Ozempic and Wegovy, weight loss is the best-known outcome — but a new study suggests the medications could also help squash depression. Investigators from Epic ...

A new study has found that antidepressant resistance is more common than was thought: 48% of people with depression have tried at least two medications without effect, while 37% have tried four or ...

Neumora halted one trial of its depression drug navacaprant and paused a pair of late-stage studies as it tries to learn from a recent phase 3 failure. The KOASTAL-1 study, which read out in January, ...